Cantourage Group SE
A European platform producing and distributing medical cannabis products to pharmacies.
HIGH | XMIL
Overview
Corporate Details
- ISIN(s):
- DE000A3DSV01
- LEI:
- 3912003NCTLO6YHA9V48
- Country:
- Germany
- Address:
- Feurigstraße 54, 10827 Berlin
- Website:
- https://www.cantourage.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cantourage Group SE is a leading European medical cannabis company that produces and distributes cannabis-based medicinal preparations. Founded in 2019, the company operates a 'fast-track' platform model, sourcing cannabis flowers and raw materials from a global network of cultivation partners. It manages the import and processing of these materials into EU-compliant pharmaceutical products at its European manufacturing hubs, handling all regulatory complexities. The product portfolio includes dried flowers, extracts, dronabinol, and pharma-grade cannabidiol, which are distributed to pharmacies through wholesalers. Cantourage also facilitates patient access to medical cannabis therapies through its telemedicine platform, Telecan.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 12:00 |
Regulatory News Service
Cantourage strengthens market presence in Poland with flower variety Gelato 33
|
English | 10.7 KB | ||
| 2025-10-30 10:08 |
Earnings Release
Q3 2025: Cantourage delivers strong operating performance in a challenging regu…
|
English | 9.7 KB | ||
| 2025-10-15 15:49 |
Regulatory News Service
Cabinet decision on the Medical Cannabis Act meets broad criticism / Cantourage…
|
English | 13.0 KB | ||
| 2025-10-08 13:01 |
Regulatory News Service
Cantourage is responding to potential developments resulting from new legal reg…
|
English | 8.3 KB | ||
| 2025-10-01 09:47 |
Board/Management Information
Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations…
|
English | 7.4 KB | ||
| 2025-10-01 09:39 |
Director's Dealing
Cantourage Group SE: Philip Schetter, Acquisition of 188,639 Shares as Part of …
|
English | 6.1 KB | ||
| 2025-09-04 09:00 |
Business and Financial Review
Cantourage Group SE Update
|
German | 12.5 KB | ||
| 2025-07-09 18:42 |
Board/Management Information
Ad-hoc-Mitteilung nach Art. 17 Marktmissbrauchsverordnung - Cantourage Group SE…
|
German | 4.6 KB | ||
| 2025-05-20 07:51 |
Earnings Release
Cantourage achieves strong and profitable growth in the first quarter of 2025
|
English | 7.4 KB | ||
| 2025-05-15 07:07 |
Earnings Release
Cantourage achieves another record revenue: EUR 11.1 million in April 2025
|
English | 6.6 KB | ||
| 2025-04-11 09:03 |
Earnings Release
Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 202…
|
English | 6.8 KB | ||
| 2025-04-10 08:52 |
Earnings Release
Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 for the fi…
|
English | 9.0 KB | ||
| 2025-03-11 08:31 |
Earnings Release
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
|
German | 7.6 KB | ||
| 2025-03-10 08:31 |
Earnings Release
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
|
German | 7.6 KB | ||
| 2025-01-16 07:30 |
Earnings Release
Legalization of cannabis brings strong growth: Cantourage Group SE increases it…
|
English | 10.0 KB |
Automate Your Workflow. Get a real-time feed of all Cantourage Group SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cantourage Group SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cantourage Group SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-02 | Think.Health Projekt M GmbH & Co. KG | Close relation | Sell | None | 72,010.80 EUR |
| 2024-11-25 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 200,000.00 EUR |
| 2024-09-13 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 105,000.00 EUR |
| 2024-07-18 | PiFriva Verwaltungs- und Beteiligungs-GmbH | Close relation | Sell | None | 140,000.00 EUR |
| 2024-06-06 | HOFY4 GmbH | Close relation | Sell | None | 345,000.00 EUR |
| 2024-05-27 | HOFY4 GmbH | Close relation | Sell | None | 7,400.00 EUR |
| 2024-05-17 | HOFY4 GmbH | Close relation | Sell | None | 140,000.00 EUR |
| 2024-05-17 | HOFY4 GmbH | Close relation | Sell | None | 1,080.00 EUR |
| 2024-02-21 | HOFY4 GmbH | Close relation | Sell | None | 63,205.88 EUR |
| 2024-02-14 | Think.Health Projekt M GmbH & Co. KG | Close relation | Sell | None | 82,415.57 EUR |
Peer Companies
